Top Biotech Companies in APAC
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Biotech Companies in APAC
BioTech News
Research Peptide Suppliers Supporting APAC Scientific Growth
Thursday, August 27, 2026
Research peptides have become a source of supply for laboratories, drug discovery and research companies, biotech firms, and universities in APAC. With research needs becoming more widespread in drug discovery, molecular biology, diagnostics, and therapeutic development, the organizations need reliable sources of high-quality peptides. This is made possible through the services of the research peptide providers, who cater to these needs through synthesis, purification, characterization, documentation, and technical support services that are in line with the needs of laboratories. The supplier relationship goes beyond just material supply, as organizations assess their suppliers
Harnessing Biotechnology for Natural Ingredient Innovation in APAC
Thursday, August 13, 2026
Fremont, CA: The Asia-Pacific (APAC) region is becoming a hub for biotechnology and natural ingredients. Many companies are seeking to produce items using environmentally friendly materials while developing new products backed by scientific research. The landscape of biotechnology and ingredient production in the APAC region is evolving, with manufacturers increasingly adopting sustainable practices. They view biotechnology and natural resources not just as separate entities, but as complementary elements that can be combined to create desirable products for consumers. Companies want to make sure their ingredients are always the same, make things efficiently and
Biological Controls Shift Crown Gall Management Upstream in APAC Nurseries
Thursday, July 02, 2026
A bacterial infection that often remains hidden until plants are established is forcing growers across Asia-Pacific to rethink where crown gall management begins. For many nursery operators and orchard owners, the issue is no longer how to deal with infected plants after symptoms appear. The bigger question is how to prevent contaminated material from entering production in the first place. That change in thinking is drawing more attention to biological crown gall control methods. The appeal is straightforward. Preventive treatments can be introduced during propagation, when intervention is still practical and before infected stock reaches commercial growers. Crown gal
Crown Gall Prevention Becomes Part of the Nursery Buying Decision in APAC
Thursday, July 02, 2026
Plant health is becoming a larger factor in nursery purchasing decisions across Asia-Pacific as growers take a closer look at the long-term risks associated with crown gall disease. A young tree or vine can appear healthy at delivery, yet an undetected infection may not become visible until after planting, when replacement costs are significantly higher. That risk is changing the conversation between growers and nursery suppliers. Questions that once focused on availability and delivery schedules increasingly extend to propagation practices and the measures used to reduce disease exposure before shipment. Biological crown gall control methods are part of that shift. Th
Biological Crown Gall Control Runs Into the Realities of Nursery Execution in APAC
Thursday, July 02, 2026
Interest in biological crown gall control is growing across Asia-Pacific, but enthusiasm only goes so far in a nursery setting. Propagation schedules are already tightly managed and introducing another treatment step can complicate routines that leave little room for delays or inconsistency. That is one reason the discussion has shifted from the products themselves to the mechanics of using them. Crown gall is largely a prevention issue. Once infected planting stock reaches the field, options become limited and the costs of replacing plants begin to rise. The effectiveness of any biological approach depends heavily on what happens before a tree or vine ever leaves the nursery.
The Growing Importance of Biological Crown Gall Prevention
Thursday, June 18, 2026
Crown gall remains one of the most damaging diseases in nursery and horticultural production because it attacks the economic value of propagation stock before plants reach the market. Tumor-like growths can make trees, vines and ornamental plants unsaleable, leaving growers with little choice but to destroy infected material. For executives responsible for agricultural inputs, the issue is not only disease suppression but the protection of production value, buyer confidence and continuity across growing seasons. The challenge is made sharper by the limited role of conventional chemical control. Crown gall has long required a preventive biological approach because once infection
